nonprofit logo

Rivkin Center For Ovarian Cancer

Learn about this cause: Is it Legit? Do I like the mission? What is the CEO's salary?

EIN: 912054035 ✦ Seattle, WA ✦ Designated as a 501(c)(3)

Overview

What is Rivkin Center For Ovarian Cancer?

The Rivkin Center for Ovarian Cancer is a nonprofit organization situated in Seattle, Washington. Known for its seed funding approach, it has an influential grant program that fosters innovative research and new researchers in the field of ovarian cancer. In the 2022 funding period, the Rivkin Center reviewed 113 applications from international sources and funded six outstanding researchers from the United States and one from British Columbia, Canada, awarding a total of $510,000. Despite ovarian cancer being underfunded by federal agencies compared to other cancers and lacking a universal screening tool, the Rivkin Center is dedicated to investing in research to improve early detection, prevention, or curative options. The organization's ultimate goal is to contribute to a world where women can live longer, healthier lives, free from the burden of cancer.


Official website here: www.rivkin.org

Is Rivkin Center For Ovarian Cancer legitimate?

Rivkin Center For Ovarian Cancer is a legitimate nonprofit organization registered as a 501(c)(3) entity. Rivkin Center For Ovarian Cancer submitted a form 990, which is a tax form used by tax-exempt organizations in the U.S., indicating its operational transparency and adherence to regulatory requirements. Donations to this organization are tax deductible.

Here are some key statistics you may want to consider:

Executive Compensation: $274,992
Professional Fundraising Fees: $0
Other Salaries and Wages: $320,642

For more financial information, click here


Official website here: www.rivkin.org

What is the mission statement of Rivkin Center For Ovarian Cancer?

The Rivkin Center for Ovarian Cancer has a mission to envision a world where women live longer and healthier lives, with cancers being either prevented, detected early, or cured. They achieve this through their grant program, which employs a seed funding approach and supports innovative research and promising scientists. In the 2022 funding period, they awarded $510,000 in scientific grants to seven researchers, recognizing the underfunding of ovarian cancer by federal agencies compared to other cancers, despite it being the most deadly gynecological cancer without a universal screening tool.


Official website here: www.rivkin.org

Who is the CEO of Rivkin Center For Ovarian Cancer?

Molly O' Connor is the Ceo of Rivkin Center For Ovarian Cancer. The CEO's salary of Rivkin Center For Ovarian Cancer is $151,846 and their total compensation is $170,425.


Official website here: www.rivkin.org

What is the revenue of Rivkin Center For Ovarian Cancer?

Rivkin Center For Ovarian Cancer's revenue in 2022 was $1,484,984.


Official website here: www.rivkin.org

Who are the executives of Rivkin Center For Ovarian Cancer and what are their salaries?

The average compensation at Rivkin Center For Ovarian Cancer during 2022 was $85,091. There are 7 employees and 50 volunteers at Rivkin Center For Ovarian Cancer.

Here are 18 key members and their salaries (Rivkin Center For Ovarian Cancer's CEO's salary is $151,846 and their total compensation is $170,425):

    Molly O' Connor (Ceo)
  • Compensation: $151,846
  • Related: $0
  • Other: $18,579

    • Wendy Rosen (Chief Dev.)
  • Compensation: $102,173
  • Related: $0
  • Other: $8,927

    • Garnet Anderson Phd (Board Member) [Trustee/Director]
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Donna Benaroya (Board Member) [Trustee/Director]
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Gloria Bensussen (Board Member) [Trustee/Director]
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Eva Corets (Board Member) [Trustee/Director]
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Audrey Covner (Board Member) [Trustee/Director]
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Charles Drescher Md (Board Member) [Trustee/Director]
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Kirsten Hart Ward (Board Member) [Trustee/Director]
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Bobbie Hinton (Board Member) [Trustee/Director]
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Andrea Rewitz Mizer (Board Member) [Trustee/Director]
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Amy P Sing Md (Board Member) [Trustee/Director]
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Melissa Rivkin (Board Member) [Trustee/Director]
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Katie Van Kessel Md (Board Member) [Trustee/Director]
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Daniel Veljovich Md (Board Member) [Trustee/Director]
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Kateri Schei (President)
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Thomas Brown Md (Vice President)
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Alex Smith (Secretary)
  • Compensation: $0
  • Related: $0
  • Other: $0


  • Official website here: www.rivkin.org

    Where can I find the form 990 for Rivkin Center For Ovarian Cancer?

    The Rivkin Center For Ovarian Cancer’s most recent form 990 was submitted in 2022 and can be accessed here


    Official website here: www.rivkin.org

    Learn more at the official website: www.rivkin.org

    Mission Statement of Rivkin Center For Ovarian Cancer

    The Rivkin Center for Ovarian Cancer is committed to a vision where women lead longer and healthier lives, achieving this goal through the prevention, early detection, or cure of various cancers. By employing a seed funding strategy, the organization supports groundbreaking research and promising researchers, as demonstrated by the 2022 funding period, during which they awarded $510,000 in grants to seven researchers in the United States and Canada. Despite ovarian cancer being the deadliest gynecological cancer and lacking a universal screening tool, federal funding agencies invest less in it compared to other types of cancer. The Rivkin Center's grantees, on average, leverage additional funding sources worth $17 for every dollar they receive from the organization, furthering their ovarian cancer research efforts.

    Impact

    This information is meant to be a general summary of Rivkin Center For Ovarian Cancer. Please take the time to review official sources before making any decisions based upon the content provided here.




    Saturday, July 20, 2024

    The impact of the Rivkin Center For Ovarian Cancer is significant in advancing research and support for ovarian cancer. The center's grant program is renowned for launching new research and researchers, attracting applications from around the world. In the 2022 funding period, the Rivkin Center awarded $510k in scientific grants to seven researchers, fostering innovation and promising developments in ovarian cancer research.

    Ovarian cancer, being one of the most deadly gynecological cancers with no universal screening tool, is often underfunded by federal agencies. However, the Rivkin Center's investments lead to a substantial multiplier effect, with awardees leveraging an average of $17 from other funding sources for every dollar received. This ripple effect amplifies the impact of the center's support, driving progress in understanding and combating ovarian cancer.

    By supporting cutting-edge research and empowering researchers, the Rivkin Center is at the forefront of the fight against ovarian cancer, ultimately striving towards a world where women can live longer and healthier lives through prevention, early detection, and improved treatments for cancers.





    Financials

    This financial information is from Propublica.

    Revenue
    Expenses
    Efficiency

    Other financial information:

    This information is from the most recently submitted tax form from this organization, which was in 2022.

  • Investment Income: $-8,929
  • Program Service Revenue: $55,681
  • Gross Receipts: $1,891,162

    • Assets and Liabilities:
  • Total Assets: $2,071,817
  • Total Liabilities: $38,462
  • Net Assets: $2,033,355
  • Programs

    Programs are reported by nonprofits in their tax forms and are normally their tax-exempt activities.

    Symposium

    Revenue

    $55,681

    Organization Details

    Founding Year

    1996

    Principal Officer

    Molly O' Connor

    Main Address

    1200 12th Ave S 1110, Seattle, WA, 98144

    NTEE Category

    Code: H30 - Medical research

    If you are a representative of Rivkin Center For Ovarian Cancer and wish to learn more about how Give Freely can help you raise funds, please click here: https://givefreely.com/nonprofits/. Our services are offered at no cost to your organization.